The Society’s Annual European Conference will be held 9-12 November 2025 in Glasgow, Scotland, UK
Lawrenceville, NJ, USA— October 13, 2025—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Joining ISPOR CEO Rob Abbott is this year’s keynote speaker David Snowden, Founder and Chief Scientific Officer of The Cynefin Co. Together they will explore global collaboration and complexity in advancing patient-centered healthcare decision making.
Plenary sessions for ISPOR Europe 2025 include the following with speakers added to the online program as they are confirmed:
Plenary 1: Patient Engagement in Healthcare Investments—A Promise or a Practice?
In this panel, key stakeholders, including payers, investors, industry, regulators, and patients, will have an open discussion about how patient engagement can be improved to lead to tangible results. The goal of this discussion is to set actionable deliverables for the next 5 years to improve access, relevance, and efficiency based on patient input and involvement.
Speakers Include:
Moderator: Joep Muijrers, PhD Gilde Healthcare Partners; Utrecht; The Netherlands
Carole Longson, PhD; University of Manchester; Manchester, England, UK
Steffen Thirstrup, PhD, MD; European Medicines Agency; Amsterdam, The Netherlands
David H.-U. Haerry, PhD; Positivrat; Zürich, Switzerland
Luc Truyen, MD, PhD; Argenx;, Boston, MA, USA
Plenary 2: Pragmatic Trials—Bridging Research and Real-World Care
This panel will explore how to disentangle the role, benefits, and challenges of pragmatic trials. The session will address questions such as: How could pragmatic trials help re-engineer the process of development into access? Can pragmatic clinical trials be part of the solution to addressing disparities and inequalities in access to clinical trials, thereby bringing faster therapeutic progress to all?
Speakers Include:
Moderator: Denis Lacombe, MD; EORTC; Brussels, Belgium
Antonella M Cardone; Cancer Patients Europe, Brussels, Belgium
Michael Zaiac, MD, PhD; Daiichi Sankyo Europe GmbH; Zürich, Switzerland
Beate Wieseler, PhD; IQWiG; Cologne, Germany
Richard Sullivan, MD, PhD; Institute of Cancer Policy, Centre for Conflict & Health Research, King's College London; London, England, UK
Natasha Azzopardi-Muscat, MD, PhD; WHO Europe; Copenhagen, Denmark Francesco Pignatti, MD; European Medicines Agency; Amsterdam, The Netherlands
Plenary 3: RWE in European Healthcare Decision Making—What's in it for Patients?
This plenary session will discuss the opportunities and challenges of real-world evidence (RWE) from a multistakeholder perspective and will explore how strategic cross-border partnerships and technological advancements—including AI—are helping to realize RWE’s full potential for patients.
Speakers include:
Moderator: Karen Facey, PhD; University of Edinburgh, Utrecht, The Netherlands
Maria Dutarte; European Patients’ Academy on Therapeutic Innovation (EUPATI); Utrecht, The Netherlands
Pall Jonsson, BSc, PhD; National Institute for Health and Care Excellence (NICE); Manchester, England, UK
Sofie Gustafsson, PhD; Pfizer; Stockholm, Sweden
Renske Los, PhD; Erasmus, PhD Erasmus MC; Rotterdam, The Netherlands
The ISPOR Short Course Program is also being offered immediately prior to ISPOR Europe 2025 on 9 November with a wide variety of courses that include cutting-edge topics such as artificial intelligence (AI), real-world evidence (RWE), health economic modeling, patient-reported outcomes, and more. All short courses do require a separate registration fee. ISPOR also provides virtual learning opportunities, full details of the available courses are available here.
ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions. The conference draws healthcare stakeholders from the region with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.
Additional information on the conference can be found at:
Conference Information | Program | Press | Exhibits & Sponsorship | Registration
###
ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website | LinkedIn | Twitter (@ispororg) | YouTube | Facebook | Instagram